Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lipase Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105969836A details a lipase YCJ01 catalyzed process for high-purity vinelactone. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN1656230A reveals enzymatic resolution for high-purity glycol ethers. Discover cost-effective supply chain solutions and scalable manufacturing processes.
Patent CN1260364C reveals a novel enzymatic hydrolysis using bulky esters for high-purity beta-amino acids, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN117587081A reveals enzymatic synthesis for high-purity vitamin E derivatives. Discover cost-effective supply chain solutions and scalable manufacturing.
Patent CN102212572B details a yeast-displayed lipase method for L-ascorbyl oleate. Achieve higher purity and cost efficiency in antioxidant manufacturing with this novel biocatalytic route.
Novel MOF-immobilized lipase catalyst enables green, high-yield production of Benzyl Carbazate. Ideal for Indoxacarb synthesis. Reliable supply chain partner.
Patent CN102212570B details a biocatalytic route for L-ascorbyl conjugated linoleate, offering high purity and cost-effective production for nutritional applications.
Patent CN100344766C details a cost-effective enzymatic resolution of 2-methyl-1-butanol using vinyl acetate, offering significant supply chain advantages for pharmaceutical intermediates.
Patent CN114921507B reveals lipase resolution for 2-oxabicyclo-[3.3.0]oct-6-en-3-one. High purity, green process, reliable supply chain for pharmaceutical intermediates.
Patent CN101104861B reveals a novel Yarrowia lipolytica lipase method for S-ibuprofen. Discover cost-effective, high-selectivity biocatalysis for pharmaceutical manufacturing.
Patent CN1425019A discloses a novel enzymatic route for vitamin D precursors, offering cost reduction in pharmaceutical intermediates manufacturing through scalable crystallization.
Discover the environmentally friendly synthesis of chiral 2,3-alkenols using lipase catalysis. A breakthrough in pharmaceutical intermediate manufacturing offering high purity and cost efficiency.
Patent CN105420285B reveals a scalable enzymatic method for producing optically active heptadecene compounds, offering significant cost reduction and supply chain reliability for agrochemical manufacturers.
Patent CN1220702A details a novel enzymatic process for producing high-purity optically active amines, offering significant cost reduction and supply chain reliability for agrochemical and pharmaceutical intermediates.
Patent CN105461606B details enzymatic hydrolysis for Ledipasvir intermediates. Achieve >99% de value and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN101045936B details a novel enzymatic resolution process using succinic anhydride, offering significant cost reduction and simplified purification for pharmaceutical intermediates.
Patent CN100404686C details enzymatic resolution of C-24 hydroxy vitamin D isomers, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN102277392B details enzymatic resolution for high-purity pharmaceutical intermediates. Offers significant cost reduction and supply chain reliability for global buyers.